Your browser doesn't support javascript.
loading
Biologic agents for asthma treatment
Allergy, Asthma & Respiratory Disease ; : 3-12, 2019.
Article in Korean | WPRIM | ID: wpr-719391
ABSTRACT
Most treatment strategies for asthma currently include inhaled corticosteroids, with the addition of long-acting beta-2-agonists or leukotriene modifiers, if necessary. However, some patients may not respond to conventional treatment. A better understanding of the pathophysiology of asthma has recently led to the development of biological agents, which have shown promising results for symptom control and future risk reduction in severe asthmatics. This article reviews currently available biologic agents, introduces related studies, and describes the subgroup of patients benefitting from each of biologic agents in the view point of precision medicine.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Asthma / Biological Therapy / Biological Factors / Adrenal Cortex Hormones / Risk Reduction Behavior / Precision Medicine Type of study: Etiology study / Prognostic study Limits: Humans Language: Korean Journal: Allergy, Asthma & Respiratory Disease Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Asthma / Biological Therapy / Biological Factors / Adrenal Cortex Hormones / Risk Reduction Behavior / Precision Medicine Type of study: Etiology study / Prognostic study Limits: Humans Language: Korean Journal: Allergy, Asthma & Respiratory Disease Year: 2019 Type: Article